Related Experiment Video
Updated: Jul 9, 2026

Polygraphic Recording Procedure for Measuring Sleep in Mice
Published on: January 25, 2016
Narcolepsy: pathophysiology and pharmacology.
1Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA. nishino@stanford.edu
Narcolepsy is a sleep disorder affecting 1 in 2000 people, characterized by excessive daytime sleepiness and cataplexy. Most cases involve hypocretin/orexin deficiency, paving the way for new diagnostic and therapeutic strategies.
Area of Science:
- Neurology
- Sleep Medicine
- Pharmacology
Background:
- Narcolepsy affects 1 in 2000 individuals, presenting with excessive daytime sleepiness (EDS), cataplexy, and REM sleep disturbances.
- Current treatments include CNS stimulants for EDS and antidepressants for cataplexy, with modafinil and sodium oxybate also used.
Purpose of the Study:
- To review the pharmacologic and pathophysiologic aspects of narcolepsy.
- To highlight recent discoveries in narcolepsy genetics and their implications.
Main Methods:
- Review of existing literature on narcolepsy.
- Discussion of genetic discoveries in animal models and human narcolepsy.
- Analysis of current and potential future treatments.
Main Results:
- Hypocretin/orexin ligand deficiency is identified in approximately 90% of human narcolepsy-cataplexy cases.
- This finding has led to new diagnostic tests, such as cerebrospinal fluid hypocretin level measurements.
Conclusions:
- Hypocretin deficiency is a major cause of narcolepsy, offering a target for future therapies.
- Hypocretin replacement therapy is a potential future treatment for hypocretin-deficient narcolepsy, though not yet available in humans.
More Related Videos
08:58Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice
Published on: June 19, 2019
10:45Simultaneous Electroencephalography, Real-time Measurement of Lactate Concentration and Optogenetic Manipulation of Neuronal Activity in the Rodent Cerebral Cortex
Published on: December 19, 2012
Related Concept Videos
Narcolepsy
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...